Search - tctmd.com

Displaying 321 - 340 of 2022

Sort: Relevancy | Date

Presentation THT 2025

Discuss Escalation Strategies for Patients in HF-CS

Presenter: Jane Wilcox

February 11, 2025

Presentation THT 2025

Position 2: It Should be Class I

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2025

Position 1: It Should be Class IIa

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2025

The Best Thing Since Sliced Bread.

Presenter: William Abraham

February 11, 2025

Presentation THT 2025

A Strategy That Has Created More Confusion Than Clarity.

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

Robotic Surgical Technique for Performing Heart Transplant

Presenter: Feras Khaliel

February 11, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Presenter: Gabriel Sayer

February 11, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Presenter: James Udelson

February 11, 2025

Presentation THT 2025

Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring

Presenter: Sandip Zalawadiya

February 11, 2025

Presentation THT 2025

Resurgence of Interest in the Role of Inflammation in HF

Presenter: Douglas Mann

February 11, 2025

Presentation THT 2025

Obesity: Assessing the Weight of the Evidence

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

MRAs Redux: New Evidence in Heart Failure

Presenter: Scott Solomon

February 11, 2025

Presentation THT 2025

Mineralocorticoid Antagonism in Heart Failure: Mechanistic Foundations

Presenter: Faiez Zannad

February 11, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

Presentation THT 2025

Winning the War on Shock: Insights From the Premier Database

Presenter: Joseph Ibrahim

February 11, 2025

Presentation THT 2025

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

Presenter: Boaz Elad

February 11, 2025

Presentation THT 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

Presentation THT 2025

Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis

Presenter: Joseph Ibrahim

February 11, 2025

Advertisement

Discuss Escalation Strategies for Patients in HF-CS

Position 2: It Should be Class I

Position 1: It Should be Class IIa

The Best Thing Since Sliced Bread.

A Strategy That Has Created More Confusion Than Clarity.

Robotic Surgical Technique for Performing Heart Transplant

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring

Resurgence of Interest in the Role of Inflammation in HF

Obesity: Assessing the Weight of the Evidence

MRAs Redux: New Evidence in Heart Failure

Mineralocorticoid Antagonism in Heart Failure: Mechanistic Foundations

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Winning the War on Shock: Insights From the Premier Database

Use of Vericiguat in Durable Left Ventricular Assist Device Patients

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content